Lymphocyte subpopulations in chickens with regressing or progressing tumors induced by Rous sarcoma virus by Munns, Paula L.
Retrospective Theses and Dissertations Iowa State University Capstones, Theses andDissertations
1-1-1990
Lymphocyte subpopulations in chickens with
regressing or progressing tumors induced by Rous
sarcoma virus
Paula L. Munns
Iowa State University
Follow this and additional works at: https://lib.dr.iastate.edu/rtd
This Thesis is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital
Repository. It has been accepted for inclusion in Retrospective Theses and Dissertations by an authorized administrator of Iowa State University Digital
Repository. For more information, please contact digirep@iastate.edu.
Recommended Citation
Munns, Paula L., "Lymphocyte subpopulations in chickens with regressing or progressing tumors induced by Rous sarcoma virus"
(1990). Retrospective Theses and Dissertations. 18548.
https://lib.dr.iastate.edu/rtd/18548
Lymphocyte subpopulations in chickens with 
regressing or progressing tumors induced by Rous sarcoma virus 
fs.v/ 
/ 9'9 tf} 
'7''0 - ~ 
c. 3 
by 
Paul a L. Munns 
A Thesis Submitted to the 
Graduate Faculty in Partial Fulfillment of the 
Requirements for the Degree of 
MASTER OF SCIENCE 
Interdepartmental Program : 
Major : 
lrTvnunobi o logy 
Invnunobiology 
Signatures have been redacted for privacy 
Iowa State University 
Ames, Iowa 
1990 
) 
LIST OF ABBREVIATIONS 
INTRODUCTION 
LITERATURE REVIEW 
i i 
TABLE OF CONTENTS 
Rous Sarcoma Virus Structure 
Genetics of Resistance and Response to RSV 
Invnune Response to RSV-Induced Tumors 
Lymphocyte Subsets: Phenotypes and Functions 
MATERIALS AND METHODS 
Virus and Injections 
Tumor Scoring Criteria 
Experimental Animals 
Lymphocyte Collection 
Labelling of Lymphocytes with MAbs 
Flow Cytometric Analysis 
Tumor-Infiltrating Lymphocyte Isolation 
Irrmunohistochemistry of Tumor Sections 
Statistical Analysis 
RESULTS 
Differences in Tumor Response Between Trials 
Comparison of PBL Subsets Between Sexes 
Effects of RSV Inoculation 
Comparison of Tumor-Regressor and -Progressor 
Differences in PBL Subsets Among Genotypes 
Isolation of Tumor-Infiltrating Lymphocytes 
Irrmunohistochemistry 
DISCUSSION 
SUMMARY 
LITERATURE CITED 
ACKNOWLEDGEMENTS 
Page 
vi 
1 
3 
3 
4 
8 
10 
16 
16 
16 
17 
20 
21 
22 
23 
25 
26 
27 
27 
27 
30 
Phenotypes 36 
44 
52 
52 
53 
62 
64 
71 
i i i 
LIST OF TABLES 
Page 
Table 1. Criteria used for describing the stages of 17 
RSV-induced tumor growth 
Table 2. Numbers of birds in each trial of the experiment 19 
divided by genotype and family designation according 
to tumor response 
Table 3. Mean tumor scores for progressor and regressor birds 28 
within weeks among trials 
Table 4. Percentages of PBL subsets in birds of different sexes 31 
within weeks 
Table 5. Percentages of PBL subsets in birds of different sexes 32 
within tumor scores 
Table 6. Comparison of mean percentages of peripheral blood 48 
lymphocyte subsets in uninoculated birds among 
genotypes 
iv 
LIST OF FIGURES 
Figure 1. Genomes of avian leukosis virus (ALV} and different 
strains of Rous sarcoma virus (RSV) 
Figure 2. Simplified scheme of cellular interactions involved 
in recognition and killing of virus-infected cells 
Figure 3. Mean tumor scores by week of progressor and 
regressor birds 
Figure 4. Weekly percentages of C04-posit ive peripheral blood 
lymphocytes in uninoculated and inoculated birds 
Figure 5. Weekly percentages of COS-positive peripheral blood 
lymphocytes in uninoculated and inoculated birds 
Figure 6. Weekly percentages of IA-positive peripheral blood 
lymphocytes in uninoculated and inoculated birds 
Figure 7. Weekly percentages of C04-positive peripheral blood 
lymphocytes in progressor and regressor birds 
Figure s. Weekly percentages of COS-positive peripheral blood 
lymphocytes in progressor and regressor birds 
Figure 9. Weekly percentages of IA-positive peripheral blood 
lymphocytes in progressor and regressor birds 
Figure 10. Percentages of C04-positive peripheral blood 
lymphocytes in progressor and regressor birds 
by tumor score 
Figure 11. Percentages of COS-positive peripheral blood 
lymphocytes in progressor and regressor birds 
by tumor score 
Figure 12. Percentages of IA-positive peripheral blood 
lymphocytes in progressor and regressor birds 
by tumor score 
Figure 13. Percentages of C04-positive peripheral blood 
lymphocytes in progressor and regressor birds 
bearing tumors increasing in size by tumor score 
Page 
5 
14 
29 
33 
34 
35 
37 
38 
39 
41 
42 
43 
45 
v 
Page 
Figure 14. Percentages of CDS-positive peripheral blood 46 
lymphocytes in progressor and regressor birds 
bearing tumors increasing in size by tumor score 
Figure 15. Percentages of IA-positive peripheral blood 47 
lymphocytes in progressor and regressor birds 
bearing tumors i ncreasing in size by tumor score 
Figure 16. Weekly percentages of C04-positive peripheral blood 49 
lymphocytes in progressor and regressor birds of 
genotype 19H 
Figure 17. Weekly percentages of CDS-positive peri pheral blood 50 
lymphocytes in progressor and regressor birds of 
genotype 19H 
Figure lS . Weekly percentages of IA-positive peripheral blood 51 
lymphocytes in progressor and regressor birds of 
genotype 19H 
vi 
LIST OF ABBREVIATIONS 
CD - cluster of differentiation 
CD4 - antigen on helper T cells 
COB - antigen on cytotoxic/ suppressor T cells 
IA - major histocompatibility complex class II antigen 
MAb - monoclonal antibody 
MHC - major histocompatibility complex 
PBL - peripheral blood lymphocyte 
RSV - Rous sarcoma virus 
T4 - human homologue for C04 
TS - human homologue for COB 
1 
INTRODUCTION 
Rous sarcoma virus (RSV) is a retrovirus that causes a sarcoma in 
chickens. In susceptible birds, tumor either regress or progress. 
Regression and progression of RSV-induced tumors are affected by both major 
histocompatibility complex (MHC)-linked genes and non-MHC-linked genes 
(Collins and Zsigray 1984). 
Few distinctions have been found that give insight into the 
dissimilarities between birds with different tumor response phenotypes. 
Powell et al . (1987) found that tumor cells in regressing RSV-induced 
tumors expressed 8-L (MHC class II) antigens, while tumor cells from 
progressing tumors did not . Perry et al. (1978) observed moderate to 
marked areas of lymphocyte infiltration and lymphocytes that were 
frequently in contact with tumor cells in regressing Rous sarcomas, whereas 
progressing tumors had less lymphocyte infiltration and lymphocyte-tumor 
cell interaction. The migration of peripheral blood lymphocytes (PBL) fr om 
chickens with regressing RSV-induced tumors was found to be inhibited by 
exposure to soluble tumor extract to a greater degree than PBL from 
chickens with progressing tumors (Cotter et al. 1976). 
The objective of this study was to gain an increased understanding of 
the mechanisms of the immune response to RSV in chickens. CD4-positive 
cells (helper T cells), CDS-positive cells (cytotoxic/ suppressor T cells) 
and IA-positive cells (B cells and activated T cells) play important roles 
in the immune response. Altered ratios of lymphocyte subsets have been 
associated with many diseases (Bach and Bach 1981). The speci fic 
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objectives of this study were to determine if peripheral blood lymphocytes 
from regressor and progressor chickens differ in their expressions of CD4, 
CDS, and IA antigens during the course of tumor growth over time or tumor 
size, and to determine if there were differences in lymphocyte subsets 
between birds of different genotypes. 
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LITERATURE REVIEW 
Rous sarcoma virus (RSV) is a retrovirus that causes a sarcoma, a 
malignant tumor of mesenchymal origin, in chickens . It was discovered by 
Rous (1911), who described the histology of sarcomas transferred by tumor 
graft into the breast muscle of the chicken as "spindle cells, usually in 
bundles, with a slight vascularizing framework" . The neoplastic tissue was 
reported as gristly and grayish white, but occasionally soft or gelatinous. 
It was discovered by Rous (1911) that the sarcoma could be transmitted by 
an agent separable from the tumor cells. This agent, RSV, was the first 
tumor virus isolated from a solid tumor. 
Rous Sarcoma Virus Structure 
RSV is a RNA virus of the family Retroviridae. The structure of the 
genome of RSV has been described. It can consist of 4 genes: gag, 
encoding the structural proteins of the virion ; pol, encoding the reverse 
transcriptase; env, encoding the envelope glycoproteins; and src, encoding 
the oncogene that is the hallmark of RSV. These genes are flanked on both 
ends by long terminal repeats (LTR) (Wang and Hanafusa 1988) (Figure 1). 
The viral oncogene, src , was derived from a cellular oncogene and encodes a 
60 kd phosphoprotein, pp6ov·src. This protein is a tyrosine kinase. The 
expression of pp6ov·src produces many structural and functional changes, 
thus leading to cell transformation (Svoboda 1988). 
The genomes of different strains of RSV have been characterized . RSV 
may have originally been formed by the insertion of src into an avian 
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leukosis virus (ALV) (Bishop 1982) (Figure 1). Schmidt-Ruppin RSV (SR-RSV) 
and Prague RSV (PR-RSV) both have genomes containing the four complete 
retroviral genes. In the genome of Bryan high -titer RSV (BH -RSV) , the src 
gene has inserted and the env sequence is mi ssi ng , making the virus 
replication-defective (Wang and Hanafusa 1988) . Many acutely transforming 
viruses are replication -defective because they have an incomplete genome , 
having lost all or part of env or gag while acquiring src. Replication-
defective RSV require an ALV as a helper virus for the production of 
infectious virus (Bi shop 1982} . These helper viruses are called Rous-
assoc iated viruses (RAV) . BH -RSV has the helper virus RAV-1, which 
provides the missing env gene products. ALV and RSV are divided into five 
subgroups: A, B, C, D, and E. The subgroup specificity is determined by 
differences in the envelope glycoproteins, 37 kd spikes (gp37) and 85 kd 
knobs (gp85}. BH - RSV (RAV -1) has a subgroup A specificity (Svoboda 1988}. 
Genetics of Resistance and Respon se to RSV 
The gp85 is important in determining resi stance of a bird to RSV-
induced tumorigenesis. Because gp85 is different for every subgroup and is 
involved in the interaction with cellular receptors, the presence of a 
given receptor may confer susceptibility, while the absence may result in 
resistance to infection . Susceptibility is dominant over resistance (Payne 
1985}. Lines of chicken embryo fibroblasts (CEF} resistant to subgroup A 
were used by Crittenden (1968} to determine the level of genetic cellular 
resistance. It was found that although resistance to infection was almost 
absolute, absorption of the virus was not affected. The genetic block 
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seemed to occur at either the level of penetration of the virus into the 
cell or at the subsequent uncoating of the virus particle. 
ALV 
SR-RSV 
PR-RSV 
BH-RSV 
LTR LTR 
gag pol env 
LTR LTR 
I s re .__~1--~g~a~g:__L_~P_o __ _J_ __ e_n_v __ .r------~~~-
LTR LTR 
.______,~-g-~ag--1~-P_o_l~....--s~rc~-~~--~ 
Figure 1. Genomes of avian leukosis virus (ALV) and different strains of 
Rous sarcoma virus (RSV). Adapted from Wang and Hanafusa (1988) 
and Bishop (1982) 
SR -RSV, Schmidt -Ruppin RSV; PR-RSV, Prague RSV; BH-RSV, Bryan 
high-titer RSV; LTR, long terminal repeat . 
In birds susceptible to the induction of RSV - induced tumors there i s a 
second level of genetic control ; this level affects the progression or 
regression of the tumor. A progressor is defined as a bird which, 
following virus inoculation, developed a large tumor that persisted or 
increased in size throughout the period of observation. A regressor refers 
to a chicken that developed a tumor that completely disappeared or 
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noticeably decreased in size during the experimental observation period 
following virus inoculation (Collins and Zsigray 1984). Regression and 
progression are affected both by major histocompatibility complex (MHC) -
linked genes and non-MHC -linked genes (Collins and Zsigray 1984) . 
The MHC in chickens is linked to the 8 blood group system, whi ch 
serves as a useful genetic marker (Schierman and Nordskog 1961). The three 
class model of the chicken MHC proposed by Pink et al . (1977) is still 
accepted. The three subregions are B-G, 8-F, and 8-L. The B-G antigens 
(class IV antigens) are found primarily on red blood cells. B-F antigens 
are chicken MHC class I antigens . They are found on almost all nucleated 
cells, including chicken erythrocytes . B-L antigens are found on B cells, 
activated T cells, and cells of the monocyte/ macrophage lineage. The 8-L 
antigens are the MHC class II antigens, also known as the IA or IA-like 
antigens. 
The MHC in chickens has been associated with disease resistance (Bacon 
1987). Chickens from the Iowa State Sl White Leghorn line (used in this 
thesis) with the 81/ 81 blood type were significantly more resistant to 
Marek' s disease (Steadham et al . 1987) and fowl cholera (Lamont et al. 
1987) than birds of the B19/B19 blood type. 
MHC-linked genes have been associated with Rous sarcoma regression and 
progression. Schierman et al. (1977) used the MHC-congenic lines of G-Bl 
and G-B2 chickens to look at regression and progression. They found that 
all G-Bl birds were progressors and most G-B2 and F1 birds were regressors. 
This indicated that the regression of RSV-induced tumors was a dominantly 
inherited trait associated with the B haplotype. They designated the MHC-
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linked gene conferri ng the abi lity to regres s RSV -i nduced tumors R-Rs-1, 
and the allele allowing progression r-Rs -1. Collins et al. (1977) al so 
found differences in 8 haplotypes as sociated with RSV tumor reg ression. 
They determined that birds from the RPRL line 61 (genotype 8
2/ 82 ) primarily 
regressed the tumors, wh il e birds from line 151 (genotype 8
5/ 85 ) almost 
invariably died with the tumors . Heinzelmann et al. (198lb) found that 
targets of 82/ 82 and 85/ 85 RSV - infected chicken embryo fibroblasts (CEF) and 
uninfected 85/ 85 CEF were lysed by lymphocytes from 82/ 82 chickens bearing 
RSV - induced tumors. They hypothesi zed that cross -reactivity between 85 
antigen and tumor-specific antigen make it difficult for the 85/ 85 chicken 
to recognize the RSV - induced tumor as foreign . 
Complementation characterized by enhanced regression in heterozygotes 
has been observed for both MHC-linked and non-MHC-linked genes. 823/826 
birds had a greater anti -tumor (regression) response than either of the 
homozygous haplotypes 823/ 823 or 826/ 826 (Brown et al. 1982) . The G-81 
(813/813 ) and G-83 (815/ 815 ) lines of chickens were found to have almost 100% 
progression of RSV-induced tumors, whereas most birds from the G-82 (86/ 86) 
line regressed the tumor (Cutting et al . 1981). A complementation effect 
was demonstrated between the two progressor G-81 and G-83 parental lines, 
whose F1 progeny predominantly regressed the tumor. Backcross data 
indicated that both complementing MHC-linked and non -MHC -linked genes were 
necessary in tumor regression (Cutting et al. 1981). 
Non -MHC-linked genes influence the regression or progression of RSV -
induced tumors. Two independent autosomal loci , Ly-4 and Th-1, which 
determine surface alloantigens on partly overlapping subsets of T cells, 
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are important. Chickens of the genotype Ly-4!/ Ly-4!, Th-1!/ Th-1! 
(abbreviated as aa/ aa) had a significantly higher ability to regress tumors 
than the other three double homozygous genotypes (aa/ bb, bb/ aa, bb/ bb) 
(Gilmour et al. 1983). In addition to Ly-4 and Th-1, a locus, Bu-1, 
determining a surface alloantigen on B lymphocytes, was examined (Gilmour 
et al . 1986) . Although the Th-1 genotype had no association with tumor 
regression, Ly-4!/ Ly-4 9 , Bu-12/Bu-1~ and Ly-42/ Ly-42, Bu -1!/ Bu-1! genotypes 
had higher levels of regression than aa/ aa or bb/ bb genotypes. Higher 
levels of regres sion to RSV-induced tumors were concluded to be associated 
with the interaction between the Ly-4 and Bu-1 loci and the complementation 
observed. 
Many other factors also affect regression and progression . Regression 
of RSV-induced tumors is influenced by age of the bird; the incidence of 
regression is higher in older chickens than in younger ones (Cotter et al. 
1973, Heinzelmann et al. 198la). Virus strain and subgroup also have an 
effect on sarcoma regression {McBride et al . 1981) . The B77 strain 
{subgroup C) produced regressi ng tumors in G-Bl birds, while strain PR-RSV 
(subgroup C) caused progres sing tumors in the same line of birds . Brown 
and co-workers {1984) found that both the B haplotype of the bird and the 
subgroup of the virus influence the anti-tumor response. 
Immune Response to RSV-Induced Tumors 
The role of the humoral invnune system in the response to RSV-induced 
tumors is controversial. The role of antibody was tested by McArthur et 
al . {1972) by using bursectomized {Bx) chickens, and no differences in 
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incidence or growth of the tumor were found between Bx and control 
chickens . In contrast, McBride et al . (1978) found that genetically 
resi stant ch ic kens became suscept i bl e t o progressi ve t umor growth foll owing 
bursectomy . Other studies found that although bursectomy had littl e or no 
effect on the response to RSV-induced t umor s , thymectomy did have an 
effect . Yamanouchi et al. (1971) found that thymectomy inhibited 
regression of primary tumors and the induction of resistance to RSV 
challenge in Japanese qua ils, but no differences were observed in qua il s 
that were bursectomized. Thymectomized chickens were found to have a 
higher incidence of tumors, l arger tumors, and higher tumor mortal i ty than 
control chickens, but Bx chickens only had a difference in tumor s ize (lam 
and l inna 1976) . These results indicate that although the role of the 
humoral immune response i s not wel l understood , cel lular immunity seems to 
play a role in the RSV- induced tumor response. 
Effects of thymect omy were not the only criteria used to eva l uate the 
role of the cell-mediated immune system in the regression and progression 
of Rou s sarcomas . Stimulat ion of peripheral blood leukocytes (PBL) with 
supernatant fluids of infected cell cultures and extracts of tumor cells 
was demonstrated in tumor -bearing birds (Israe l and Wainberg 1977) . The 
blastogenic response was observed during regressi on of the tumors . 
Whitfill and co-workers (1984) stimulated PBL from regressor and progressor 
l ines of chickens with concanavalin A (Con A) and phytohemagglutinin -P 
(PHA-P). They found no differences in dose dependency of blastogenes i s 
with Con A, but at high concentrations of PHA-P regressor PBL were 
stimulated more than progressor PBL. Also , regressor leukocytes exh i bi ted 
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sensitization to sarcoma antigens not observed with the progressor 
leukocytes. Cell-mediated cytotoxicity was also used as an indication of 
cell-mediated immunity. Spleen cells and thymus cells from regressor 
Japanese quails were cytotoxic to cultivated Rous sarcoma cells, while no 
cytotoxic effects were observed using lymphoid cells from progressor quail 
(Hayami et al. 1972}. Wainberg et al . (1974} found spleen cells from RSV-
induced tumor-bearing chickens to be more reactive against autochthonous 
than allogeneic neoplastic target cells in vitro. This was observed in 
chickens with progressively growing sarcomas. Compelling evidence for the 
major role of cell -mediated immunity in RSV-induced tumor regression was 
shown by Whitfill et al . (1986} . They demonstrated that the transfer of 
sensitized histocompatib 1e blood lymphocytes and peritoneal macrophages 
from regressor donor birds to progressor rec i pients resulted in the 
eradication of growing tumors in age-matched chickens. 
Lymphocyte Subsets : Phenotypes and Functions 
The cellular immune system can be divided into subsets of cells 
involved in tumor regression. Subsets of lymphocytes with different 
functional roles have been described . The functional subsets bear 
different surface proteins . Monoclonal antibodies (MAbs} are used to 
detect the specific cell surface proteins on the functional subsets. B and 
T lymphocytes are two of the important subsets. B lymphocytes, which 
synthesize immunoglobulins, are an important facet of the cellular immune 
system. They are characterized by the cell surface MHC class II antigens 
(IA antigens} and immunoglobulins (Sell 1987}. Two of the major functional 
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subpopulations of T cells are helper T cells and cytotoxic/ suppressor T 
cells (Parnes 19S9). Lymphocyte subsets can be distinguished by cluster of 
differentiation (CD) antigens. Helper T cells are identified by the CD4 
antigen. In humans, this antigen is designated T4, and the MAb OKT4 
identifies this subset; in the mouse , the MAb L3T4 designates this 
population. OKT4 binds to 55 -60% of the peripheral blood T cell population 
and identifies cells necessary for the generation of cytotoxic T cells 
(Reinherz et al. 1979b) . This MAb also characterizes T cells that provi de 
the signals necessary for the differentiation of B cells into 
immunoglobulin-producing cells (Reinherz et al. 1979a). Helper T cells are 
restricted by class II MHC antigens (Swain 19S3); they are activated by the 
recognition of a foreign antigen in conjunction with self MHC class II 
antigens (Sell 19S7). 
The cytotoxic and suppressor T cell population, which are generally 
class I MHC restricted (Swain 19S3) , is defined by the CDS antigen. TS, 
the human homologue of CDS, is recognized by the MAb OKT5. The symbols Ly2 
and Lyt2 are used to designate the same population in mice. Approximately 
20% of human peripheral blood T cells are bound by OKT5 . OKTS -bound cells 
are minimally responsive to soluble antigens and have a poor proliferative 
response to PHA. The cytotoxic function of this subpopulation was 
established using cell-mediated lympholysis, and the suppressor function 
was demonstrated by the suppressive effect of Con A stimulated cells on 
autologous cell proliferation in mixed lymphocyte culture (MLC) (Reinherz 
et a 1. l 9SO) . 
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Helper and cytotoxic T cells have been described in the chicken (Chan 
et al . 19SS; Lillehoj et al. 19SS). MAbs developed by Lillehoj et al. 
(19S8) against the avian homologue of CDS ant igen stained 1S% of peripheral 
blood lymphocytes (PBL); the MAbs against the CD4 homologue bound 19% of 
PBL. The Con A-induced proliferation of spleen cells was reduced after 
pretreatment with anti-CDS antibody and complement (C). Pretreatment with 
anti-CD4 antibody and C resulted in substantially less inhibition of Con A-
induced proliferation than treatment with anti-CDS antibody and C. 
Treatment of spleen cells with anti-CDS and C, but not anti -CD4 antibody 
and C, resulted in a significant reduction in the cytotoxic activity. This 
agreed with the established functions of helper T cells and 
cytotoxic/suppressor T cells . The anti -CD4 MAbs immunoprecipitated a 55 kd 
band; anti -CDS MAbs invnunoprecipitated 33 -35 kd proteins under reducing 
cond i tions. 
MAbs produced by Chan et al . (19SS) against avian CD4 and CDS bound 
45% and 15% of PBL, respectively . The removal of CDS-positive cells 
inhibited the cytotoxic activity induced by allogeneic lymphocyte 
stimulation, and the removal of CD4-positive lymphocytes inhibited pokeweed 
mitogen- induced interleukin-2 (IL-2) production. The anti-CDS antibody 
immunoprecipitated molecules of 34 kd under reducing conditions, and anti-
CD4 antibody identified a 64 kd protein. 
The anti -CDS MAbs produced by Lillehoj et al. (198S) and Chan et al. 
(19S8) seem to bind similar subsets . However, the percentages of PBL bound 
by the anti-CD4 antibodies and the molecular weights of the 
invnunoprecipitated proteins were different . 
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A simple scheme for the roles of helper T cells and cytotoxic T cells 
in the recognition and destruction of virus-infected cells involves the 
recognition of virus antigen in conjunction with MHC antigens (Figure 2). 
The T cell receptor on the surface of helper T cells recognizes the virus 
antigen together with class II MHC antigens on the surface of antigen 
presenting cells (APC). This , along with the release of interleukin-I (Il-
l) by the APC stimulates the helper T cell to release interleukin-2 (Il-2) . 
IL -2 stimulates T cells, and induces cytotoxic T cell precursors 
recognizing the same viral antigen with MHC class I antigens on the APC to 
differentiate into activated cytotoxic T cells capable of killing virus-
infected cells . The helper T cell is also affected by the IL-2, and 
becomes activated. This system is a model for killing tumor cells as well 
as virally-infected cells (Sell 1987). 
Both helper (CD4) and cytotoxic (CDS) T cells have a role in tumor 
regression. Flamand et al. (1990) found that both CD4 -positive and C08-
positive T cells were important in vivo for induction of immunological 
control on tumor growth. The generation of cytotoxic T cells is necessary 
for the regression of a tumor . The CD4 -positive cells may act as helpers 
be releasing factors that activate cytotoxic cell precursors after 
recognition of tumor-derived antigens displayed by antigen presenting 
cells. It was shown (Mills and North 1983) that the passive transfer of 
non-cytotoxic T cells sensitized to the tumor does not cause regression of 
the tumor until a sufficient number of cytotoxic T lymphocytes have been 
produced in the draining lymph nodes in T cell -deficient recipients. They 
postulated that the infusion of sensitized non-cytotoxic lymphocytes gave 
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Figure 2. Simplified scheme of cellular interactions involved in 
recognition and killing of virus-infected cel ls . Adapted from 
Sell (1987, Chap. 10} 
the tumor-bearing recipient the ability to generate cytotoxic T lymphocytes 
against the tumor . Helper T cell s have been shown to act as inducers for 
the generation of tumor-specific cytotoxic T lymphocytes (Schild et al. 
1987, Yamamoto et a 7. 1987). Kosugi et a 7. ( 1987) demonstrated that the 
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generation of tumor-specific cytotoxic T lymphocytes was dependent upon 
helper factors released from activated helper T cells . Different functions 
of the T cell subsets were found using Moloney sarcoma virus (MSV)-induced 
tumors as a model (Bateman et al. 1987). They found that L3T4+ cells were 
necessary for the protection against MSV-induced tumors in normally 
resistant unprimed mice, while Lyt-2• cells were not. A second experiment 
evaluating the role of the two subsets of T cells in the protection of 
unprimed mice through adoptive immunization. It was found that although 
Lyt-2• T cells were able to confer full tumor resistance, the population of 
L3T4• positive T cells failed to do so. Other workers (Ershler et al. 
1989) suggested that the functional importance of the helper T cell may be 
in early tumor cell recognition and destruction, but after the tumor has 
become established, the helper T cell has a lesser role in the restraint of 
tumor growth . 
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MATERIALS AND METHODS 
Virus and Injections 
The virus used was a mixture of BH-RSV and the helper virus RAV-1. It 
will be referred to throughout this thesis as RSV. It was kindly donated 
by Dr. L. Crittenden (U.S. Department of Agriculture, Agriculture Research 
Service, Regional Poultry Research Laboratory, East Lansing, MI) . The 
stock virus was obtained from supernatants from line 0 primary chicken 
embryo fibroblasts, which lack endogenous viral genes, infected with BH-
RSV(RAV-1) (Crittenden, personal convnunication 1990). The stock solution 
of the virus was kept at -70C. The virus stock was diluted with PBS pH 7.2 
to a concentration of 200 FFU (focus forming units) / 50 µl. The working 
dilution was kept in an ice water bath until used. Each chicken was 
injected with 50 µl (200 FFU) sub-dermally in the wingweb of the wing not 
containing the wingband . 
Tumor Scoring Criteria 
The tumor forms in the wingweb at the point of injection. The wingweb 
of each bird was examined visually and palpated weekly following the 
injection of the virus. Any observable tumor was assigned a tumor score 
based on the criteria described in Table 1 (Collins et al . 1977). The 
control birds and any bird without an observable tumor were given a tumor 
score of zero. 
After a period of 7 or 8 weeks, each chicken was categorized as either 
a regressor or a progressor. A chicken was designated as a regressor if 
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the last tumor score observed was a zero, or if a decrease in the tumor 
score was observed between the last two weeks evaluated. Any chicken that 
died prior to termination of the experiment, and any chicken that showed an 
increase in the tumor score over the last 2 weeks or maintained the same 
tumor score over the last 2 weeks of observation was designated as a 
progressor. 
Table 1. Criteria used for describing the stages of RSV-
induced tumor growth (Collins et al. 1977) 
Tumor Score 
0 
1 
2 
3 
4 
5 
6 
Description of Tumor 
No palpable tumor. 
Small tumor 0-0.5 cm in diameter. 
Tumor 0.5-1.5 cm in diameter . 
Tumor 1.5 cm in diameter to 1/ 2 the wingweb. 
Tumor 1/ 2 the size of the wingweb to slightly 
less than the wingweb. 
Tumor fills the wingweb . 
Tumor fills the wingweb, engulfs the wing. 
Bird is moribund. 
Experimental Animals 
Chickens were from the SI line of White Leghorns at the Iowa State 
Poultry Center at Iowa State University . The Sl line was derived from a 
cross of two inbred commercial lines (Nordskog et al. 1973) . Since 1978, 
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it has been maintained as sublines homozygous for major histocompatibility 
complex (MHC) haplotype (81/ 81 or 819/ 819) and for the humoral immune 
response to the synthetic antigen glutamic acid -alanine-tyrosine (GAT), 
high (H) or low (L) (Nordskog and Cheng I988). Thus, a bird was of the 
genotype IH, IL, I9H, or I9L . 
Chicks were kept in battery brooders until 4 weeks of age , when they 
were moved to suspended wire cages where they were kept throughout the 
experiment . Food and water were available ad libitum. 
Chicks were hatched from each of the four genotypes . Full- s ibling 
groups with at least IO chicks were selected, and the 4-week-old chicks 
were injected with RSV . All birds formed tumors, which were scored weekly 
for 7 weeks, and each bird was designated as a regressor or a progressor . 
Families within the four groups were then assigned a designation of 
progressor, regressor, or mixed, depending on the designation of the birds 
within the family . A family was designated as mixed if there was an 
approximately equal number of progressors or regressors within the family. 
Full-siblings and half-siblings of the tested birds were used to set 
up matings to produce chicks for the research presented in this thesis . 
Five groups of birds were selected based on haplotype and response to RSV-
induced tumors. The groups selected were : IH regressor, IH mixed (both 
progressors and regressors), IL mixed, I9H mixed, and I9L progressor. 
Because the birds in the IH mixed group were later found to be 
predominantly regressors , the two groups were combined after trial 2 and 
were subsequently referred to as IH regressors . Four trials of the 
peripheral blood lymphocyte (PBL) analysis experiment were done; trial 4 
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contained only uninoculated birds. Trials 1, 2, and 4 were performed on 
the progeny of the siblings of the original tested birds. The birds used 
in trial 3 were progeny of siblings of the birds used in the other three 
trials. Table 2 contains the numbers and genotypes-family tumor response 
of the birds selected for use in each trial. 
Table 2. Numbers of birds in each trial of the experiment divided by 
genotype and family designation according to tumor response 
Genot~Qe-famil~ tumor resQonse 
RSV lH-Reg• lH-Mixb IL-Mix 19H-Mix 19L-Progc 
Trial 1 + 10 5 5 5 5 
1 0 1 2 1 
Trial 2 + 8 7 5 5 5 
0 1 1 2 1 
Trial 3 + 14 0 4 5 3 
1 0 1 1 2 
Tri a 1 4 + 5 0 5 5 5 
8 Reg • regressor. 
~ix "' mixed. 
cProg z progressor. 
The number of birds in a trial was selected as being the maximum 
number of samples easily handled in a day in the laboratory. More bi rds 
from the lH genotype were selected than the other genotypes because a 
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balanced number of progressor and regressor birds was desired, and the 
genotypes that had a mixed response of progression/ regression to RSV-
induced tumors tended to have a higher percentage of progressors than 
regressors at the cond i tions used in this study . Birds were distributed 
randomly in the groups by sex . Trial 3 had only 31 birds because 4 of the 
birds in the experiment did not produce tumors. The data from these 4 
birds were discarded . 
Lymphocyte Collection 
Blood samples were collected from all birds before the injection of 
the virus and at weekly intervals for 7 weeks following the injection. 
Approximately 3 ml of blood was collected from the jugular vein of each 
bird each week by using a heparinized syringe. 
Whole blood samples were placed in glass test tubes siliconized with 
Sigmacote (Sigma Chemical Co . , St . Louis, MO) and centrifuged for 10 
minutes at 60 x g. The leukocytes suspended in the serum were pipetted off 
by using a siliconized pasteur pipette. These cells were then pelleted by 
centrifugation at 600 x g. If too few cells (determined by visual 
inspection of the pelleted cells in the tube) were collected, the remaining 
portion of the whole blood sample was recentrifuged at 60 x g, and the 
additional leukocytes were pipetted off and pooled with those collected 
from the first centrifugation. The collected leukocytes were pelleted at 
600 x g, the serum was discarded, and the cells were then resuspended in 1 
ml of the wash buffer composed of 1.1 x Dulbecco's phosphate buffered 
saline (OPBS) (Sigma Chemical Co . , St. Louis, MO), 2% fetal calf serum 
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(FCS), and 0.1% NaN3 • The cells were again pelleted, the wash buffer wa s 
discarded, and approximately 1 ml of fresh wa sh buffer was added. The 
cells were resuspended in the wash buffer by using a siliconized pasteur 
pipette, diluted by using trypan blue dye, and the concentration of viable 
cells was determined for each sample by usi ng a hemacytometer. The volume 
containing 1 x 106 cells was determined, and 1 x 106 cells from each sample 
were placed in each of 4 siliconized test tubes. Approximately 1 ml of the 
wash buffer was then added , the cells were pelleted by centrifugation, and 
the wash buffer wa s discarded. 
Labelling of Lymphocytes with MAbs 
Monoclonal antibodies (MAbs) to the antigens CD4, COB, and IA were a 
gift from Dr. Hyun Lillehoj (United States Department of Agriculture -
Agriculture Research Service, Beltsville, MD) . MAbs used for trial s 1, 2, 
and 4 were in ascites fluid; those used for trial 3 were in culture 
supernatant. Working dilutions of the Mabs were based on the 
recommendations by Hyun Lillehoj (personal convnunication 19B9, 1990). MAbs 
were diluted by using the wash buffer. The ascites fluids were used at 
dilutions of 1:10, 1:10, and 1:50 for CD4, COB, and IA, respectively; the 
supernatants were used at dilutions of 1:5, 1:10, and 1:10 for CD4, COB, 
and IA, respectively. 
Each of the 4 tubes of leukocytes prepared from each blood sample was 
labelled stained with anti -CD4, anti -COB, or anti-IA MAb or used as the 
background control. All tubes labelled with a MAb received 100 µ1 of the 
antibody dilution, and the control tubes received nothing. All tubes were 
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shaken gently and then incubated at SC for 30 minutes . The cells were 
washed twice following incubation using approximately 1 ml of the wash 
buffer. After cells were pelleted and the wash buffer was drained off the 
second time, the secondary antibody was added . 
The secondary antibody was a fluoroisothiocyanate (FITC)-labelled 
antibody. Trial 1 used affinity purified FITC-labelled goat anti-mouse lgG 
(ICN Invnunobiologicals, Lisle, IL) . All other trials were done using FITC-
labelled anti -mouse IgG F(ab') 2 fragments absorbed with human serum (Sigma 
Chemical Co., St. Louis, MO) . Secondary antibodies were used at a dilution 
of 1:100. All washed and drained tubes received 100 µl of the secondary 
antibody. They were incubated at SC for 30 minutes following a gentle 
shaking. After incubation, the cells were washed three times by using 
approximately 1 ml of the wash buffer . 
The cell s were fixed following the last wash. Equal volumes (usually 
100 µl) of buffer (1.1 x DPBS + 0.1% NaN3) and a 2% solution of electron 
microscopy (EM) grade formaldehyde (Electron Microscopy Sciences, Fort 
Washington, PA) in buffer were added to each tube. This resulted in a 
final fixing solution containing 1% formaldehyde . The cells were then 
resuspended by shaking, covered with aluminum foil, and stored at SC until 
analysis was executed on the flow cytometer. 
Flow Cytometric Analysis 
Antibody-labelled cells from tri als 1, 2, and 4 were analyzed on an 
EPICS 7S2 flow cytometer (Coulter Electronics Corporation, Hialeah, FL); 
cells from trial 3 were analyzed on an EPICS Profile I flow cytometer 
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(Coulter Electronics Corporation, Hialeah, FL). Lymphocytes were 
distinguished from other white blood cells on the basis of their forward 
angle light scatter (related to cell size) versus right angle scatter 
(related to cellular granularity) ·(Muirhead et al. 1985). An electronic 
analysis gate was set on the cluster of lymphocytes containing the 
fluorescent cells to eliminate background fluorescence. Green fluorescence 
was determined on a 256 channel histogram in linear fluorescence units. 
Percentages of positive cells were reported as the percentage of cells from 
the negative control subtracted from the test sample to give the net 
percentage of positive cells. 
Tumor-Infiltrating Lymphocyte Isolation 
Collection of tumor - infiltrating lymphocytes (TIL) was adapted from a 
procedure by Trail and Yang (1985). RSV-induced tumors at various stages 
of tumor growth were excised using a scalpel from the wingwebs of birds 
killed by cervical dislocation. The excised tumor was placed in calcium-
and magnesium-free Hank's buffered salt solution (HBSS) (Sigma Chemical 
Company, St. Louis, MO) on ice . Feathers attached to the tumor were 
removed and the weight of the tumor was recorded. The tumor was then 
minced into small pieces by using a scalpel. The minced pieces were 
suspended in approximately 10 ml of calcium- and magnesium-free HBSS with 
0.125% collagenase (Sigma Chemical Company, St . Louis, MO) and homogenized 
in a glass homogenizer for approximately 1 minute. The resulting mixture 
was stirred slowly for 1 hour. A steel strainer (mesh size 80) was used to 
obtain a single-cell suspension. Buffer consisting of 1.1 x DPBS, 2% FCS, 
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and 0.1% NaN3 was used to dilute the suspension approximately 1:3; the 
cells were then pelleted by centrifugation at 600 x g for 15 minutes. The 
pelleted cells were resuspended in 20 ml of buffer and pelleted at 600 x g 
twice. The cells were resuspended in 5 ml of buffer, layered on 15 ml of 
Ficoll-Paque (Pharmacia LKB Biotechnology Inc . , Piscataway, NJ) and 
centrifuged at 400 x g for 30 minutes. The interface band containing 
viable tumor cells and lymphocytes was harvested. Cells were washed twice 
using 5 ml of the buffer. Washed cells were layered onto a discontinuous 
Percell (Sigma Chemical Co., St. Louis, MO) gradient. The gradient was 
formed by diluting 9 ml of Percell with 1 ml of 10 x HBSS. This stock 
solution was further diluted to 20, 40, and 65% of the stock. Two ml of 
each density were layered in the order of decreasing density to form the 
gradients. The cells were either suspended in 2 ml buffer on top of the 
20% density, or resuspended in the 2 ml of 65% Percell used for the bottom 
layer. Gradients were centrifuged for 30 minutes at 400 x g, and cells at 
the interface between the 40 and 65% Percell gradients were collected. 
These cells were washed twice with 1 ml of buffer and then resuspended in 1 
ml buffer. The volume of 1 x 106 cells was determined and the lymphocytes 
were labelled with MAbs. 
Variations in the above procedure were done to test the efficacy of 
the modifications. These included deleting the Ficoll -Paque 
centrifugation, performing the collagenase digestion at room temperature, 
and collecting the tumors into HBSS at room temperature. 
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Invnunohistochemistry of Tumor Sections 
Cross-sections less than 3 mm thick were excised from the tumors 
collected for TIL analysis. A spleen from a normal chicken was used as a 
positive control. Sections were fixed in 10% neutral buffered formalin and 
imbedded in paraffin blocks. Sections 4 µm thick were cut and placed on 
poly-L-lysine-coated slides. Tissue sections were deparaffinized and 
rehydrated in a series of baths: 2 for 5 minutes in xylene, 2 for 3 
minutes in 100% alcohol, 2 for 3 minutes in 95% alcohol, 1 for 3 minutes in 
70% alcohol, 1 for 3 minutes in distilled water. Sections were trypsinized 
using different concentrations of trypsin for varying time periods. 
Solutions of 0.1%, 0.05%, and 0.025% solutions of trypsin (Sigma Chem Co . , 
St. Louis, MO) and CaCl were used at incubation periods of 0, 10, 15, 20, 
and 30 minutes at 37C. Slides were warmed in 0.05M pH 7.6 tris twice for 5 
minutes. Sect ions were exposed to 3% H202 at room temperature for 10 
minutes, followed by 2 washes for 5 minutes. Sections were stained using 
methods described by Bourne (1983). Tissue sections were blocked using 
normal horse serum (NHS) (obtained locally) in tris/ PBS (1:20) for 20 
minutes at room temperature. Excess serum was removed by blotting, and a 
MAb specific for C03, a cell surface marker on all T cells, obtained from 
Dr. Chen-Lo Chen (University of Alabama at Birmingham, Birmingham, AL} was 
applied to the tissue section. The section was incubated in a humidity 
chamber for approximately 20 hours at room temperature. The slides were 
wa shed 3 times with 1% NHS in 0.05M tris, which was used for all subsequent 
wa shes. Incubation for 30 minutes at room temperature in horse anti-mouse 
biotinylated secondary antibody (Vector Laboratories Inc., Burlingame, CA) 
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diluted 1:200 in tris/ PBS was the next step. Following 3 washes, the 
tissue sections were incubated with streptavidin peroxidase (BioGenics 
Laboratories, San Ramon, CA) diluted 1: 100 in tris/ PBS for 40 minutes at 
room temperature. Sections were washed, 3-amino-9-ethylcarbazole (AEC) 
solution (Polysciences Inc., Warrington, PA) was added to the tissue 
slides, and slides were incubated until a reddish color appeared or for 20 
minutes. Tissue sections were counterstained with Gill ' s stain and NH4• 
for approximately 30 seconds each. Slides were coverslipped, mounted, and 
observed by using a light microscope . 
Statistical Analysis 
Data were analyzed using general linear models procedures (SASR 
Institute Inc. 1985). Differences between means were determined using 
Duncan ' s multiple range test. Standard errors of least squares means were 
obtained. 
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RESULTS 
Differences in Tumor Response Between Trials 
Percentages of peripheral blood lymphocytes (PBL) positive for CD4, 
CDS, and IA cell surface markers were measured in samples from individual 
birds. Trials differed in the percentages of progressor and regressor 
birds within a trial (Table 3) and in the mean tumor score of a trial. The 
mean tumor scores averaged over time of trials 1, 2, and 3 were 1.76, 2.02, 
and 0.93, respectively; trials 1 and 2 had significantly higher (p<0.05) 
mean tumor scores than trial 3. Differences in the tumor scores among 
trials within weeks were also observed (Table 3). Trials 1 and 2 did not 
have significantly different mean tumor scores for progressing tumors 
between weeks 0 and 6, or for regressing birds at every week except week 2. 
Significantly lower (p<0.05) mean tumor scores were found in trial 3 for 
most weeks in both tumor response groups than trials 1 and 2. The data 
from trial 3 were not included in subsequent analyses. Explanations for 
this are given in the discussion. Figure 3 shows the differences in tumor 
growth between progressor and regressor birds from trials 1 and 2, with 
mean tumor scores for each week. 
Comparison of PBL Subsets Between Sexes 
Data from all birds in trials 1, 2, and 4 were analyzed for 
differences associated with sex. Females made up 61% and males made up 39% 
of these birds . At week 6, female birds had higher percentages of CD4-
positive and CDS-positive PBL than male birds. All other weeks showed no 
Table 3. Mean tumor scores for progressor and regressor birds within weeks among trials1 
TRP2 Tri a 1 n %3 0 1 
Week 
2 3 4 5 6 
Pro- 1 12 40 0 0. 3+ . 1511 3.3+.1411 4. l+.21 11 4.6+.3411 4.6+ . 5811 4.6+.51 11 
2 19 63 0 0.3+. 1211 3.1+.11 11 - II 3.9+.2411 - II 3.7+.2011 gressor 3. 7+ . 16 4.0+ .30 
o.o±:. 2311 - b - b - b - b 3.0±:.51 11 3 5 19 0 1. 6± . 22 1.8±. 32 2.4±.40 2.4±. 40 
Re- 1 18 60 0 0.0+.1211 2. 4+ .1211 3. 1+.1711 2.9+.21 11 l .8+ . 2711 1. 6+. 2411 
2 11 37 0 o. 1+.1611 - b 3 .o+. 2211 2.1+.2111 I.6+.3511 1. o+. 31 11b gressor 3.2+ . 15 
3 21 81 0 0. 0±: .11 11 1.3±:. ll c - b - b - b - b 1. 4± .16 1.0±.20 0.8±.25 0.5±.22 
1Means shown are least squares mean ± standard error of the least squares mean. 
2Tumor response phenotype . 
7 
4.6+. 34 11 
- be 3.2+.31 
3.o±:.45c 
1. O+ .1711 
o.1+ . 1511b 
- b 0.4±. 21 
3Percentage of total birds within a replicate having the indicated tumor re spon se . 
ll,b,cMean tumor scores not sharing superscripts within a week within a tumor response are 
significantly different (p<0.05). 
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Figure 3. Mean tumor scores by week of progressor and regressor birds 
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significant differences in PBL subsets between sexes (Table 4). No 
significant differences were observed between birds of different sexes 
bearing tumors of the same size {Table 5). 
Effects of RSV Inoculation 
PBL from uninoculated birds in trials 1, 2, and 4 were compared at 
each week with PBL from birds in trials 1 and 2 inoculated with RSV. 
Uninoculated birds had higher percentages of C04-positive PBL than 
uninoculated birds at all weeks except two ; the difference was 
significantly higher (p<0 .05) at weeks 0, 1, 4, and 7 compared to 
inoculated birds (Figure 4) . Only at weeks 5 and 6 post-inoculat ion did 
inoculated birds have significantly higher (p<0 . 05) percentages of C04-
positive PBL than uninoculated birds. 
A higher percentage of COS-positive PBL was found for uninoculated 
birds than inoculated birds at all weeks except two (Figure 5). 
Significantly higher (p<0.05) percentages of COS-positive PBL were found in 
uninoculated birds than in inoculated birds at weeks 0, 2, and 7; 
inoculated birds had a significantly higher (p<0.05) percentage of COS-
positive PBL than uninoculated birds only at week 1. No significant 
differences were found between the groups at weeks 3, 4, 5, or 6. 
Uninoculated birds had higher percentages of IA-positive PBL than 
inoculated birds at all weeks except one; IA-positive PBL were found at 
significantly higher (p<0 .05) percentages in uninoculated birds than 
inoculated birds at weeks 1, 2, and 4 post-inoculation (Figure 6). No 
significant differences were observed at other weeks. 
Table 4. Percentages of PBL subsets in birds of different sexes within weeks 1 
Lym~hocyte Subsets 
CD4 CD8 IA 
Female Male Female Male Female Male 
Week 
0 5.1±.31 4.4±.38 10 .8±.69 10.0±.86 9. 5±.43 9.7±. 53 
1 3.7±.28 3.0± .35 14 . 7±1.1 14.1±1.4 7.0±.42 7.0±. 54 
2 3.3±. 28 2.8±.35 15 . 4±1. 0 16.5±1.3 9.0±. 58 9.2±. 73 
3 3.4±. 23 3.0±.29 17 . 8±1. 2 15 .7±1.5 9.3±.56 10 . 4±.70 
4 3. 5±.30 2.9±.36 15 .0±.79 11.7±.96 9.0±.94 8.3±1.1 
5 6.4+.52 6.4+ .64 18 .0+1.5 16 .4+1.8 10.3±.68 11. 2±.84 
6 6. o±. 30• - b 15 . 2±.86• - b 10 . 7±. 50 9. 7±. 58 4.6±.35 12 . 1±1.0 
7 9.8±1.4 8.1±1. 7 14 . 1±.75 12 .5±.91 10 .0±. 60 9.8±. 75 
1Means shown are least squares mean ± standard error of the least squares mean. 
··~eans in a row within a lymphocyte subset with different superscripts are signifi cantly 
different (p<0.05) . 
w .... 
Table 5. Percentages of PBL subsets in birds of different sexes within tumor scores1 
L~mQhoc~te Subsets 
C04 COB IA 
Female Male Female Male Female Male 
Tumor Score 
0 5.7±.31 4.6±.40 15 . 5±. 51 13.1±.64 9 .8±. 29 9.7±.37 
1 4. 7±. 63 4.7±.69 14.7±2.3 14.7±2.5 9.3±1.1 8.8±1.3 w N 
2 2.8±.65 3.7±.56 14 . 7±1.6 14. 2±1. 4 8 .6±1.5 9. 4±1. 2 
3 3.9±.34 3.9±.39 14.0±.92 14.5±.94 8 .4±.53 8.8±.54 
4 4.1±. 52 4. 5±. 71 15 .0±1.0 15 .8±1.4 8 . 7± . 56 9. 4±.74 
5 4.5±. 63 2. 7±1.3 15 . 1±1. 7 9.08±3.5 8. 0± . 67 10.4±1.4 
6 3.8±.48 2 .8±. 90 10 .3±2.1 9.36±3.9 7.7±1.5 6.7±2.7 
1Means shown are least squares mean ± standard error of the least squares mean. 
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Figure 4. Weekly percentages of C04-positive peripheral blood lymphocytes 
in uninoculated and inoculated birds. The n values for 
uninoculated birds were 30 at all weeks ; the n values for the 
inoculated birds were 60 , 60, 60, 50, 48, 46, and 42, at weeks 
0, 1, 2, 3, 4, 5, 6. and 7, respectively 
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Figure 5. Weekly percentages of CDS-positive peripheral blood lymphocytes 
uninoculated and inoculated birds. The n values for 
uninoculated birds were 30 at all weeks ; the n values for the 
inoculated birds were 60, 60 , 60, 60 , 50, 48 , 46, and 42, at 
weeks 0, 1, 2, 3, 4, 5, 6, and 7, respectively 
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Figure 6. Weekly percentages of IA-positive peripheral blood lymphocytes 
in uninoculated birds. The n values for uninoculated birds 
were 30 at all weeks; the n values for the inoculated birds 
were 60, 58 , 57, 59, 48 , 48 , 46 , and 41 , at weeks 0, 1, 2, 3, 
4, 5, 6, and 7, respectively 
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Comparison of Tumor-Regressor and -Progressor Phenotypes 
RSV-inoculated birds were designated as a regressor or progressor bird 
based on the bird 's tumor response phenotype. Percentages of PBL subsets 
averaged over time were compared between regressor and progressor birds in 
trials 1 and 2. Regressor birds had significantly higher (p<0.01) 
percentages of C04-, COB-, and IA-positive cells than progressor birds. 
Regressor birds had mean percentages of cells positive for C04, COB, and IA 
of 4.3, 15.1, and 9.4, respectively; mean C04-, COS-, and IA-positive PBL 
percentages were 3.5, 12 .9, and 8.0, respectively, for progressor birds. 
PBL subsets from regressors and progressors were also compared at 
weekly time intervals. Regressor birds had higher percentages of C04-
positive cells than progressor birds at all weeks (Figure 7). At week 6, 
regressor birds had a significantly higher (p<0.05) percentage of C04-
positive PBL than progressor birds . 
Regres sor birds had higher percentages of COS-positive cells than 
progressor birds at all weeks except two; a significantly higher (p<0.05) 
percentage of COS -positive PBL was found in regres sors than in progressors 
at week 2 (Figure 8). 
A higher percentage of IA-positive cells was observed in regressor 
birds than progressor birds at all weeks except one (Figure 9). Regressor 
birds had a significantly higher (p<0.05) percentage of IA-positive PBL at 
weeks 3 and 5 than progressor birds. No s ignificant differences of PBL 
subsets were observed between progressor and regressor birds at the other 
weeks. 
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Figure 7. Weekly percentages of CD4 -positive peripheral blood lymphocytes 
in progressor and regressor birds. The n values for progressor 
birds and regressor birds were 30 and 29, respectively, for 
weeks 0 through 3; after week 3, the n values for regressor 
birds and progres sor birds were 29 and 19 , respectively 
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Figure 8. Weekly percentages of COS -positive peripheral blood lymphocytes 
in progressor and regressor birds. The n values for progressor 
and regressor birds were 30 and 29, respectively , for weeks 0 
through 3; after week 3, the n values for regressor birds and 
progressor birds were 29 and 19 , respectively 
O/o 
p 
0 
s 
I 
t 
I 
v 
e 
c 
e 
I 
I 
s 
39 
a 
12 >-············································· ............................................................................................................................ .. 
a 
10 ,__ ......................................................................... . b 
b 
8 >-· .......................................................... I ...................................................................... . 
6 >--· 
4 >-· ................. m ................ ~ .............. .. 
2 >--· 
0 1 2 3 4 5 6 7 
Week 
- Regressor l!m!!l Progressor 
6·6Means with a week with different letters are significantly 
different. 
Figure 9. Weekly percentages of IA-positive peripheral blood lymphocytes 
in progressor and regressor birds . The n values for progressor 
and regressor birds were 30 and 29, respectively, for weeks 0 
through 3; after week 3, the n values for regressor birds and 
progres sor bi rd s were 29 and 19, respectively 
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The kinetics of tumor growth varies between birds. This difference in 
ki netics can be resolved by comparing PBL subsets between regressor and 
progressor birds with tumors of approximate ly the same size . Data f rom 
RSV-injected regressor and progres sor birds with tumors of the same size 
from trials 1 and 2 were analyzed for differences in lymphocyte subsets . 
Regressor birds had higher percentages of CD4 -positive cells at all 
tumor sizes than progressor birds (Figure 10) . No significant differences 
in CD4 -positive PBL were found between progressor and regressor birds with 
tumors of similar size . 
Differences in the percentages of CDS-positive PBL were found between 
regressor and progressor birds with tumors of the same size (Figure 11); 
regressor birds had higher percentages than progressor birds at all tumor 
scores except one. Regressor birds had significantly higher (p<0 .05) 
percentages of CDS -positive PBL than progressors with tumors at scores 2, 
3, and 4. 
Regressor birds had a higher percentage of IA-positive PBL at all 
tumor scores and a significantly higher (p<0.05) percentage of IA-positive 
PBL at the tumor score 3 than progressor birds (Figure 12) . 
To separate the effects of the descending phase of tumor growth from 
the ascending phase, a data set was generated which eliminated information 
from the descending phase of tumor growth gathered from birds with tumors 
that decreased in size. Phenotypically progressor or regressor birds 
bearing tumors of the same size that were increasing or stable in size were 
compared . Although regressor birds had higher percentages at four tumor 
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Figure 10. Percentages of CD4-positive peripheral blood lymphocytes in 
progressor and regressor birds by tumor score. The n values 
at tumor scores of 0, 1, 2, 3, 4, and 5 for progressor birds 
were 58 , 2, 4, 53, 39, and 29, and for regressor birds were 96, 
19, 27, 53, 32, and 4, respectively 
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Figure 11. Percentages of COS-positive peripheral blood lymphocytes in 
progressor and regressor birds by tumor score . The n values 
at tumor scores of 0, 1, 2, 3, 4, and 5 for progressor birds 
were 58 , 2, 4, 53 , 39, and 29, and for regressor birds were 
96 , 19, 27 , 53 , 32, and 4, respectively 
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different . 
Figure 12. Percentages of IA-posi tive peripheral blood lymphocytes in 
progressor and regressor birds by tumor score. The n values 
at tumor scores of 0, 1, 2, 3, 4, and 5 for progressor birds 
were 57 , 2, 52, 37 , and 29 , and for regressor birds were 94 , 
18, 26, 52, 32, and 4, respectively 
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scores , no significant differences in percentages of C04-positive PBL were 
found between regressor and progressor birds with tumors at the same tumor 
score (Figure 13). Regressor birds had significantly higher {p<0.05) 
percentages of COS-positive PBL than progressor birds at tumor scores of 2, 
3, and 4 {Figure 14). No significant differences were observed between 
regressor and progressor birds with tumors of the same si ze for percentage s 
of IA-positive peripheral lymphocytes, but regressor birds had higher 
percentages than progressor birds at all tumor scores {Figure 15) . 
Differences in PBL Subsets Among Genotypes 
Data from all uninoculated birds in the four trials were evaluated for 
differences in PBL subsets among genotypes. Birds of genotype IH had a 
significantly higher percentage of CD4 -posit ive PBL than birds of the other 
genotypes {Table 6). The percentage of COS-positive PBL was significantl y 
lower (p<0.05) in birds of genotype IL than in birds of the other three 
genotypes. 19H birds had a significantly higher {p<0.05) percentage of IA-
positive PBL than all other genotypes; IH birds had a significantly higher 
{p<0.05) percentage of peripheral lymphocytes bearing the IA antigen than 
IL and 19L birds , although a significantly lower {p<0.05) percentage than 
the 19H birds. 
Tumor response phenotypes were confounded with the genotypes of the 
birds. Genotypes lH, 19H, IL, and 19L had 4: 11 , 1:1, 9:1, and 9:1 ratios 
of progressor birds:regressor birds, respectively . Only the 19H genotype 
had an even ratio. Inoculated 19H birds from replicates 1 and 2 were 
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Figure 13. Percentages of CD4 -positive peripheral blood lymphocytes in 
progressor and regressor birds bearing tumors increasing in 
size by tumor score. The n values at tumor scores of 0, 1, 
2, 3, 4, and 5 for regressor birds were 57, 5, 9, 35 , 25, and 
3, and for progressor birds were 58, 2, 4, 53, 39, and 29, 
respectively 
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Figure 14. Percentages of CDS-positive peripheral blood lymphocytes in 
progressor and regressor birds bearing tumors increasing in 
size by tumor score. The n values at tumor scores of 0, 1, 
2, 3, 4, and 5 for regressor birds were 57, 5, 9, 35, 25, and 
3, and for progressor birds were 58, 2, 4, 53, 39, and 29, 
respectively 
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Figure 15. Percentages of IA -positive peripheral blood lymphocytes in 
progressor and regressor birds bearing tumors increasing in 
size by tumor score. The n values at tumor scores of 0, 1, 
2, 3, 4, and 5 for progressor birds were 57, 2, 4, 52 , 37, and 
29, and for regressor birds were 55, 5, 9, 34, 25, and 3, 
respectively 
4S 
evaluated for differences in PBL subsets between the regressor birds and 
progressor birds. No significant differences were found in percentages of 
CD4-positive PBL between regres sor and progressor 19H birds at any week 
(Figure 16). Higher percentages of COS-positive cells were observed for 
regressor birds than progressor birds at all weeks except two; regressor 
birds had significantly higher (p<0.05) percentages of COS-bearing PBL than 
progressor birds at weeks 4 and 5 (Figure 17) . No significant differences 
were observed at the other weeks. Percentages of IA-positive PBL were not 
significantly different between progressor and regressor 19H birds 
(Figure lS) . 
Table 6. Comparison of mean percentages of peripheral blood lymphocyte 
subsets in uninoculated birds among genotypes 1 
PBL Subset 
C04 cos IA 
Genotype n 
lH 64 7 .3+.6S82 16 .3+.S48 10.4+.57 b 
19H 7S - b 5.0+.61 14.4"+.768 12. 9"+. 51 a 
IL 64 - b - b S. 23"+. 57c 4.6+ .6S ll.2+ .S4 
19L 70 - b 15 .s:±.ao• 8.61±.54c 5.3±.64 
1Means are least squares mean ± standard error of the least 
squares mean. 
2Means within a column with different superscripts are 
significantly different (p<0.05) . 
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Figure 16. Weekly percentages of C04 -positive peripheral blood lymphocytes 
in progressor and regressor birds of genotype 19H. The n 
values for regressor birds were 5 at all weeks, and the 
progressor birds had n values of 5, 5, 5, 5, 3, 2, 2, and 1 
at weeks 0, 1, 2, 3, 4, 5, 6, and 7, respectively 
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Figure 17. Weekly percentages of CDS -positive peripheral blood lymphocytes 
in progressor and regressor birds of genotype 19H. The n 
values for regressor birds were 5 at all weeks, and the 
progressor birds had n values of 5, 5, 5, 5, 3, 2, 2, and 1 at 
weeks 0, 1, 2, 3, 4, 5, 6, and 7, respectively 
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Figure 18. Weekly percentages of IA-positive peripheral blood lymphocytes 
in progressor and regressor birds of genotype 19H. The n 
values at weeks 0, 1, 2, 3, 4, 5, 6, and 7 for regressor birds 
were 5, 5, 4, 5, 5, 5, 5, and 5 and for progressor birds were 
5, 5, 5, 4, 3, 2, 2, and 1, respectively 
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Isolation of Tumor - Infiltrating Lymphocytes 
The isolation of tumor infiltrating lymphocytes from RSV-induced 
tumors was not consistently successful. Too few cells were obtained for 
analysis from tumors weighing less than 1.5 grams . The few viable cells 
remaining after Ficoll-Paque separation severely limited the number of 
cells available; occasionally this step wa s not done. The collection of 
the tumor into ice -cold HBSS and performing the collagenase digestion in an 
ice bath sometimes increased the viability of the cells as determined by 
the Ficoll-Paque gradient. TIL isolation was not consistently successfully 
accomplished on enough tumors to give sufficient results for anal ysis {data 
not shown) . 
lnvnunohistochemistry 
An unsuccessful attempt was made to establish a positive control by 
using a chicken spleen and a MAb {C03) that binds all T cells . None of the 
trypsinization or primary antibody incubation time variations gave a 
positive result. Recent evidence by other researchers has indicated that 
formalin -fixed, paraffin-embedded tissues are not satisfactory for use in 
th is protocol (K. A. Schat, Cornell University, Ithaca, NY, personal 
communicati on). 
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DISCUSSION 
The role of cellular immunity in Rous sarcoma virus-induced tumor 
response has been established (Hayami et al . 1972, Whitfill et al. 1986, 
Yamanouchi et al. 1971). However, few distinctions have been found that 
give insight into the dissimilarities between birds with different tumor 
response phenotypes . Powell et al. (1987) found that tumor cells in 
regressing RSV-induced tumors expressed B-L (IA-like) antigens, while tumor 
cells from progressing tumors did not. Perry et al. (1978) observed 
moderate to marked areas of lymphocyte infiltration and lymphocytes that 
were frequently in contact with tumor cells in regressing Rous sarcomas, 
whereas progressing tumors had less lymphocyte infiltration and lymphocyte -
tumor cell interaction . PBL from chickens regressing RSV-induced tumors 
were found to be inhibited from migrating by exposure to soluble tumor 
extract to a greater degree than PBL from chickens with progressing tumors 
(Cotter et al . 1976). 
CD4-positive cells (helper T cells), CDS-positive cells 
(cytotoxic/suppressor T cells) and IA-positive cells (B cells and activated 
T cells) play important roles in the inrnune response. Altered ratios of 
lymphocyte subpopulations have been associated with many diseases (Bach and 
Bach 1981). The ratio of helper T cells:cytotoxic/suppressor T cells was 
increased in patients with multiple sclerosis, autoimmune hemolytic anemia, 
and myasthenia gravis. A decrease in the percentage of helper T cells and 
a reduced helper T cell:cytotoxic/suppressor T cell ratio are 
characteristic of acquired immune deficiency syndrome (AIDS) (Fahey et al. 
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1984) and cervical intraepithelial neoplasia {Turner et al. 1988); both 
diseases are associated with viral infections and immunosuppression . 
Peripheral blood mononuclear cells isolated from patients with non -
Hodgkin ' s lymphoma had a significant reduction in the numbers of B cells 
and T cells compared to cells from healthy controls {Murray et al. 1980) . 
Melendro et al. (1983) found that patients with active systemic lupus 
erythematosus, a connective tissue disease, had lower percentages of TS 
cells than patients with the inactive disease , but that patients with the 
active disease had decreased percentages of T4 cells . Monoclonal 
antibodies to T lymphocyte subsets in chickens have recently been developed 
and characterized {Lillehoj et al. 1988, Chan et al . 1988), enabling the 
comparison of the different subsets between birds with regressing and 
progressing RSV-induced sarcomas. 
The objective of this study was to gain an increased understanding of 
the mechanisms of the immune response to RSV . The specific objectives were 
to determine if PBL from regressor and progressor chickens differ in their 
expressions of CD4, CDS , and IA antigens during the course of tumor growth 
by week or tumor score, and to determine if differences in lymphocyte 
subsets exist among birds of different genotypes. 
Inoculated birds from trial 3 had significantly different kinetics of 
tumor formation, a smaller mean tumor score, and a lower percentage of 
progressor birds than trials 1 and 2 {Table 3) . These differences were 
caused by a decrease in titer of the virus used in trial 3; the cause of 
the decrease in virus titer is unknown. The differences were in agreement 
with other results that found that lower doses of virus result in 
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relatively higher frequencies of regression (Collins and Zsigray, 1984). 
Data from the inoculated birds in trial 3 were not included in the analys i s 
because the genetic mechanisms of regression and progression vary at 
different virus doses. 
No differences in PBL subsets were observed between male and femal e 
birds at any week, except week 5, or at any tumor score (Tables 4 and 5) . 
One of the few differences between sexes noted in the literature was that 
female birds had fewer incidences of metastasis than males, which was 
postulated to be due to a hormonal influence (Collins et al . 1986) . 
Differences in tumor growth kinetics between birds progressing and 
regressing RSV-induced tumors were shown in Figure 3. Tumor regression 
generally occurred between weeks 3 and 5. Regressing tumors reached a 
highest mean tumor score of 3. Differences between regressors and 
progressors were evident after week 2. These observations were important 
considerations in the interpretation of the results. 
Inoculation of birds with RSV caused a reduction in the percentages of 
CD4-, CDS-, and IA -positive cells in the peripheral blood compared with 
uninoculated birds at most weeks (Figures 4, 5, and 6). The extremely high 
percentage of CD4-positive cells in the uninoculated birds at week 7 was 
believed to be due to a technical error (mislabelled tube of antigen used) 
that week for trial 4, because no percentages of CD4-positive PBL that high 
were observed for any other birds in the other trials at week 7 or any 
other week. This reduction in percentages of PBL subsets is consistent 
with reports on human connective tissue diseases that found lower 
percentages of T4 and TS PBL in diseased patients than in normal controls 
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(Melendro et al. 19S3). The reduction could be due to the migration of 
cells bearing these antigens to the site of RSV injection and tumor 
formation. The increase in the percentage of cytotoxic/suppressor T cells 
in the peripheral blood of inoculated birds compared to control birds 
between weeks 0 and 1 could be an indication of an early proliferative 
response in the effector cell populations caused by the virus inoculation. 
Higher percentages of CD4-, CDS-, and IA-positive cells averaged over 
time were found in regressor birds than progressor birds. Regressor birds 
tended to have higher percentages of PBL positive for CDS and IA than 
progressor birds at weeks 2 through 6 (Figures Sand 9). This occurred 
during the time that the fate of the tumor was becoming evident, and may 
indicate that these subsets are more readily available or have a greater 
inducibility in regressor birds compared to progressors . 
Peripheral lymphocyte subsets between birds bearing progressing and 
regressing tumors at the same tumor stage were compared to account for 
differences in the kinetics of tumor growth between birds. Although 
differences were not significant, birds with a regressor tumor phenotype 
had higher percentages of CD4-, CDS-, and IA-positive cells at almost all 
tumor scores (Figures 10, 11, and 12). These results may be masked by 
differences in tumor growth kinetics when data were analyzed by week. The 
higher percentages of CDS-positive and IA-positive cells in regressor birds 
than progressor birds at tumor scores of 2, 3, and 4 may contribute to the 
regression of the tumors in some birds. It should be noted that most 
tumors from regressor birds reached a score of 3 before regression 
occurred. 
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Because the data set used for Figures 10-12 contained data from tumors 
both increasing and decreasing in size, a data set was generated to compare 
the ascending stages of tumor growth between regressors and progressors 
(Figures 13-15). Progressors had higher percentages of C04-positive cells 
and COS-positive cells at some tumor scores. Regressor birds had 
significantly greater percentages of CDS-positive cells than progressor 
birds at tumor scores of 2, 3, and 4. Chandler and Yang (19Sl) found no 
differences in total T or B cell levels in the peripheral blood of dogs 
with progressing or regressing canine transmissible venereal sarcoma 
(CTVS) . Higher percentages of tumor infiltrating T cells were found in 
regressing tumors than progressing tumors. The percentages of Tµ 
lymphocytes, which express the IgMFc receptor and have a suppressive effect 
on pokeweed mitogen -driven B cell proliferation, and T lymphocytes, which 
7 
express the IgGFc receptor and induce the proliferation of B cells in 
response to pokeweed mitogen, were analyzed in the peripheral blood of dogs 
with CTVS (Trail and Yang 19S5). Dogs with progressing tumors had 
significantly higher percentages of T lymphocytes in peripheral blood than 
7 
dogs with early-regressing tumors, which were defined as tumors rapidly 
decreasing in volume. If lgGFc receptors identify a cytotoxic or 
suppressor T cell population, these results are in agreement with the data 
presented here. Regression may be controlled by the ability of a bird to 
generate large numbers of cytotoxic/suppressor T cells, helper T cells, and 
possibly B cells or activated T cells, or by the increased availability of 
these cells in birds capable of regressing RSV-induced tumors. 
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To avoid the confounding of genotypes with the effects of RSV 
injection on lymphocyte subsets (demonstrated previously), the data were 
analyzed for genotypic differences in lymphocyte subsets between 
uninoculated birds only. Differences among genotypes were found in the 
uninoculated birds. IH birds had higher percentages of CD4-positive PBL 
than the other genotypes and had more IA-positive PBL than IL and I9L 
birds. Birds of this genotype were more resistant to Marek 's disease 
(Steadham et al. I987) and fowl cholera (Lamont et al . I987), as well as 
containing the only regressor family observed in the preliminary screening. 
The IH birds were al so found to be the only one of the four genotypes that 
had both a high interleukin-2 activity and a high mitogen response to Con A 
(Knudtson et al. I990). The higher percentages of subsets containing the 
helper T cells and B cells, whi ch are both involved in the generation of an 
antibody response, may be explained by the selection of these birds for 
high antibody response to GAT . However, as these birds are also tend to be 
more resistant to both viral and bacterial infections, the availability of 
these subsets may contribute to general invnune responsiveness. Birds of 
the IL genotype were found to have a mixed population of progressor and 
regressor birds in the preliminary screening, but were predominantly of the 
progressor phenotype in the experimentally inoculated birds. Uninoculated 
birds of this genotype were found to have lower percentages of all three 
subsets than the other genotypes . These birds were selected for low 
antibody response to GAT, and the decreased availability of the various 
peripheral lymphocyte subsets may lower the general invnune responsiveness. 
Genotype differences in percentages of CD4- and CDS-positive cells were 
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also found in two congenic inbred lines of chickens by Hala et al . (1990}. 
Although they postul ated that T cell subset differences might be 
responsible for the RSV response differences between the lines, they did 
not examine subsets during the course of an RSV tumor response, as did the 
current study. 
Because genotype influenced tumor re sponse , and differences among 
genotypes were found for the percentages of PBL subsets, a more powerful 
analysis of the relationship of PBL subsets with tumor response was 
conducted by comparing the equal numbers of regressor and progressor birds 
within the 19H genotype. These birds were of the same genotype, but of 
different tumor response phenotypes, thus allowing a more valid assessment 
of the relationship of tumor response phenotype and lymphocyte subsets 
between regressor and progressor birds. These regressor birds tended to 
have higher percentages of CDS-positive and IA-positive cells than 
regressor birds at weeks 3, 4, and 5, during which regression occurred. 
This gives further evidence for the association of the cytotoxic/suppressor 
T cells and activated T cells and B cells with tumor regression. 
Although many invnunological diseases in humans have been evaluated for 
percentages and/ or ratios of various lymphocyte subsets (Bach and Bach 
1981}, few cancers have been examined for differences in lymphocyte 
subpopulations. McCluskey et al . {1983} found that patients with advanced 
malignant breast cancer have fewer helper T cells and an increased number 
of cytotoxic/suppressor T cells in peripheral blood compared to normal 
controls, patients with benign breast cancer, or malignant breast cancer in 
the early stages. Abnormalities in circulating lymphocyte subsets were 
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found in patients with untreated lung cancer (Ginns et al. 1982). Patients 
with adenocarcinoma had a decreased percentage of cytotoxic/suppressor T 
cells in the peripheral blood . Bernengo et al. (1983) found reduced 
percentages of helper T cells in melanoma patients with metastases compared 
to normal controls; cytotox ic/suppressor T cells were significantly reduced 
in long -surviving, non -metastatic, and metastatic melanoma patients 
compared to controls. A decrease in helper T cells was consistent between 
the different tumors, but the differences in percentages of 
cytotoxic/suppressor T cells were contradictory. Reduced numbers of C04-
positive cells could either shift the ratio of helper:cytotoxic/suppressor 
T cells toward suppression , or, through the decrease in lymphoproliferative 
signals mediated by lymphokines, such as IL -2, released by helper T cells. 
Increased numbers of COS -positive cells could also shift the immune 
response toward suppression, while a decrease may be due more to a 
reduction in the numbers of cytotoxic T cells. 
A major disadvantage in human cancer research is the difficulty of 
obtaining patients bearing tumors at the same stage of growth. The 
experimental model described in this thesi s has many advantages for cancer 
research. One advantage is that the kinetics of tumor growth can be 
standardized by evaluating tumors at different stages of growth and to some 
extent by the dose of the virus. Because the exact time of exposure to the 
cancer-inducing agent is known, data can be collected in the early stages 
of cancer growth , before the tumor is detectable. This system is a model 
for the comparison of factors involved in the spontaneous regression versus 
progression of tumors. 
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This study found increased percentages of helper T cells, 
cytotoxic/suppressor T cells, and IA-positive lymphocytes in regressor 
birds compared to progressor birds. The greater availability of these 
subsets in birds able to regress the tumor compared to birds that progress 
the tumor may influence the tumor response. The presence of significant 
differences in lymphocyte subsets among the uninoculated birds of different 
genotypes, combined with the association of genotype and tumor response, 
also support this conclusion . 
Further elucidation of the roles of lymphocyte subsets in tumor 
regression could be obtained in future studies by separating the functional 
subsets in the cytotoxic/suppressor T cell population . The role of the B 
cells could also be determined using anti-invnunoglobulin antibody . These 
subsets could be analyzed within the tumor tissue as well as the peripheral 
blood, if the tumor-infiltrating lymphocytes could be isolated consistently 
and without loss of specific subsets, and invnunohistochemistry was 
accomplished on frozen sections . The evaluation of tumor infiltrating 
lymphocyte subsets between progressing and regressing RSV-induced tumors 
may allow greater understanding of the mechanisms of regression . 
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SUMMARY 
Rous sarcoma virus (RSV ) causes a sarcoma i n chickens. The regress ion 
or progression of the tumor i s dependent upon both major hi stocompat i bil ity 
complex (MHC) -linked genes and non -MHC - linked genes (Collins and Zsigray 
1984). Although the role of the cellular invnune system has been 
establi shed to be important in the regres s ion of RSV-induced tumors, few 
differences between regressor and progressor birds have been described in 
the literature . The objective of this study was to gain an increased 
understanding of the mechanisms of the invnune response to RSV. 
The specific objectives were to determine if PBL from regressor and 
progressor chickens differ in their expressions of CD4 (helper T cel l 
antigen), COB (cytotoxic/ suppressor T cell antigen), and IA (MHC cl ass II 
antigen) during the course of tumor growth by week or tumor score, and to 
determine if differences in lymphocyte subsets exist among birds of 
different genotypes. 
Increased percentages of helper T cells, cytotoxic/ suppressor T cells, 
and IA-positive lymphocytes were found in regressor birds compared to 
progressor birds. The greater availability of these subsets in birds able 
to regress the tumor compared with bi rds that progress the tumor may 
influence the tumor response . Significant differences in lymphocyte 
subsets among the uninoculated birds of different genotypes, and 
differences in progressor and regressor birds within a genotype supported 
this conclusion. 
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This study describes an experimental model for cancer research that 
has many advantages. The kinetics of tumor growth can be controlled, and 
data can be collected in the early stages following tumor induction. 
Future studies could further elucidate the roles of the different 
lymphocyte subpopulations in tumor regression. The cytotoxic/ suppressor T 
cell population should be separated and the individual functional roles 
evaluated . Tumor infiltrating lymphocyte subsets in regressing birds 
should be analyzed and compared to allow greater understanding of the 
mechanisms of regression . 
64 
LITERATURE CITED 
Bach, M.-A., and J.-F . Bach. 1981. Imbalance in T cell subsets in human 
diseases . Int. J . Immunopharmacol. 3(3) : 269 -273 . 
Bacon, L. D. 1987 . Influence of the major histocompatability complex on 
disease res istance and productivity . Poult. Sci. 66 :802 -811. 
Bateman, W. J . , E. J . Jenkinson, and J. J. T. Owen. 1987 . T-cell immunity 
to murine Moloney sarcoma virus - induced tumours: L3T4• T cells are 
necessary for resistance to primary sarcoma growth, but Lyt-2• T cells 
are required for resi stance to secondary tumour cell challenge. 
Immunology 61:317-320. 
Bernengo, M. G. , F. Li sa, P. Puiatti , M. Meregalli, G. Berruto, and G. 
Zina . 1983. T-cell subsets in melanoma patients evaluated by anti-T-
cell monoclonal antibodies. Thymus 5: 223 -233. 
Bishop, J. M. 1982 . Retroviruses and cancer genes. Adv. Cancer Res. 
37:1-32. 
Bourne, J. A. 1983 . Handbook of invnunoperoxidase staining methods. Dako 
Corporation, Santa Barbara, Calif. 38 pp. 
Brown, D. W. , W. M. Coll i ns, and W. E. Briles. 1984. Specificity of B 
genotype response to tumors induced by each of three subgroups of RSV. 
Immunogenetics 19:141 - 147. 
Brown, D. W. , W. M. Collins, P. H. Ward, and W. E. Briles. 1982. 
Complementation of major histocompatibility haplotypes in regress ion of 
Rous sarcoma virus- induced tumors in noninbred chickens . Poult. Sci. 
61:409 -413. 
Chan, M. M., C. -L. H. Chen, L. L. Ager, and M. D. Cooper. 1988. 
Identification of the avian homologues of manvnalian CD4 and CDS 
antigens. J. Invnunol . 140(7) :2133-2138. 
Chandler J. P. and T. -J. Yang. 1981. Canine transmissible venereal 
sarcoma: distribution of T and B lymphocytes in blood, draining lymph 
nodes and tumours at different stages of growth. Br. J. Cancer 44 :514 -
521. 
Collins, W. M., W. E. Briles, R. M. Zsigray, W. R. Dunlop, A. C. Corbett, 
K. K. Clark , J . L. Marks, and T. P. McGrail. 1977. The B locus (MHC) 
in the chicken: association with the fate of RSV - induced tumors. 
Invnunogenetics 5:333-343. 
65 
Collins, W. M., W. R. Dunlop, R. M. Zsigray, R. W. Briles, and R. W. Fite . 
1986. Metastasis of Rous sarcoma tumors in chickens is influenced by 
the major histocompatibility (B) complex and sex . Poult. Sci . 65 :1642 -
1648. 
Collins, W. M. and R. M. Zsigray . 1984. Genetics of the respon se to Rous 
sarcoma virus-induced tumours in chickens. Anim. Blood Groups Biochem. 
Genet. 15 : 159- 171. 
Cotter, P. F., W. M. Collins, W. R. Dunlop, and A. C. Corbett. 1976. 
Detection of cellular invnunity to Rous tumors of chickens by the 
leukocyte migration inhibition reaction . Poult. Sci . 55:1008-1011. 
Cotter, P. F., W. M. Collins, W. R. Dunlop , and A. C. Corbett. 1973. Ho st 
age dependency of regression of Rous sarcomas of chickens . Cancer Res. 
33:3310-3311. 
Crittenden, L. B. 1968. Observations on the nature of a genetic cellular 
resistance to avian tumor viruses. J . Natl. Cancer Inst. 41:145-153. 
Cutting, J. A. , D. H. Watanabe , F. R. Strebel , and R. A. McBride . 1981 . 
Complementing MHC- and non -MHC - linked genes and resistance to avian 
sarcoma virus-induced tumours in inbred lines of chickens. J. 
Invnunogenet. 8:215-223 . 
Ershler, W. B., R. G. Klopp, A. L. Moore, S. L. Krauss, and G. Ranges . 
1989 . Increased susceptibility to inoculated Lewis lung carcinoma (3LL) 
but unaltered tumor growth i n mice treated with monoclonal antibody to 
L3T4 on mouse T-helper cells. Cancer Invest. 7(4):339-343. 
Fahey, J. L., H. Prince , M. Weaver, J. Groopman , B. Visscher, K. Schwartz , 
R. Detels. 1984. Quantitative changes in T helper or T 
suppressor/ cytotoxic lymphocyte subsets that distinguish acquired invnune 
deficiency syndrome from other irrmune subset disorders. Am . J . Med . 
76:95-100. 
Flamand, V., C. Biernaux, M. Van Mechelen, T. Sornasse, J. Urbain, 0. Leo , 
and M. Moser. 1990 . Invnune surveillance: both CD3.CD4• and CD3.CD8+ T 
cells control in vivo growth of P815 mastocytoma. Int. J. Cancer 
45:757-762. 
Gilmour, D. G., W. M. Collins, T. L. Fredericksen, B. Auclair, K. K. Clark, 
and W. E. Urban , Jr. 1983. Influence of non -MHC T lymphocyte 
alloantigens on regression of Rous sarcomas in the chicken. 
Invnunogenetics 17:43-54. 
66 
Gilmour, D. G. , W. M. Collins, T. L. Freder icksen, W. E. Urban, Jr. , P. F. 
Ward, and N. L. DiFronzo . 1986. Genetic interaction between non -MHC T-
and B-cell alloantigens in response to Rous sarcomas in chickens. 
Invnunogenetics 23 : 1-6. 
Ginns , L. C., P. 0. Goldenhe im, L. G. Miller, R. C. 
B. Colvin , G. Goldstein , P. C. Kung, C. Hurwitz , 
T- lymphocyte subsets in smoking and lung cancer : 
antibodies and flow cytometry. Am. Rev . Respir . 
Burton, L. Gillick, R. 
and H. Kazemi . 1982. 
analys is by monoclonal 
Dis . 126 : 265 -269 . 
Hala, K. , G. Book, 0. Vainio , and H. S. Lillehoj. 1990 . Percentage of 
co4• and cos• lymphocytes is in chicken under MHC control . Proc . XXII 
Intl. Conf. Animal Genet. East Lans ing , MI . {Abstr . 7. 4.2) . 
Hayami , M., I. Hellstrom, K. E. Hellstrom, and K. Yamanouchi. 
mediated destruction of Rous sarcomas in Japanese quails . 
Cancer 10:507-517 . 
1972 . Ce 11 -
Int. J. 
Heinzelmann, E. W. , K. K. Clark, W. M. Collins, and W. E. Briles . 198la. 
Host age and major histocompatibility genotype influence on Rous 
sarcoma regres si on in chickens . Poult . Sci . 60:2171 -2175 . 
Heinzelmann, E.W., R. M. Zsigray , and W. M. Collins . 198lb. Cross-
reactivity between RSV -i nduced tumor antigen and B5 MHC alloantigen in 
the chicken. Inrnunogenetics 13:29-37. 
Is rael , E. , and M. A. Wainberg . 1977. Development of cellular ant i-tumor 
invnunity in chickens bearing tumors induced by Rous sarcoma virus . 
J. Invnunol . 118(6):2237-2242 . 
Knudtson, K. L., M. G. Kaiser , and S. J . Lamont . 1990 . Genetic control of 
interleukin -2- like activity is distinct from that of mitogen response in 
chickens . Poult. Sc i. 69 :65-71 . 
Kosugi, A., T. Yoshioka, T. Suda, H. Sano , Y. Takahama, H. Fugiwara, and 
T. Hamaoka . 1987 . The activation of L3T4• helper T cells assisting the 
generation of anti -tumor Lyt -2• cytotoxic T lymphocytes: requirement 
of Ia-positive antigen-presenting cells for processing and presentation 
of tumor antigens. J. Leuk . Biol. 42 :632-641. 
Lam, K. M., and T. J. Linna. 1976 . Impaired host defense against XC cell-
induced tumors in thymectomized and in bursectomized chickens. Cancer 
Res. 36 :1710-1713. 
Lamont , S. J ., C. Bol in, and N. Cheville. 1987. Genetic resistance to 
fowl cholera is linked to the major histocompatibility complex . Invnuno -
genetics 25:284-289. 
67 
Lillehoj, H. S. , E. P. Lillehoj, D. Weinstock, and K. A. Schat. 1988. 
Functional and biochemical characterizations of avian T lymphocyte 
antigens identified by monoclonal antibodies . Eur . J. Irrvnunol. 
18:2059-2065 . 
McArthur , W. P. , E. A. Carswell, and G. J. Thorbecke. 1972 . Growth of 
Rous sarcomas in bursectomized chickens. J. Natl . Cancer Inst. 49 : 
907-909 . 
McBride, R. A., J . A. Cutting, L. W. Schierman, F. R. Strebel, and D. H. 
Watanabe . 1981. MHC gene control of growth of avian sarcoma virus-
induced tumours in chickens: a study on the role of virus strain . 
J. Irrvnunogenet. 8:207-214. 
McBride, R. A., D. H. Watanabe, and L. W. Schierman. 1978. Role of B 
cells in the expression of genetic resistance to growth of Rous 
sarcoma in the chicken. Eur. J. Irrvnunol . 8:147-149 . 
McCluskey, D. R., A. D. Roy, W. P. Abram , and W. M. C. Martin . 1983. 
T lymphocyte subsets in the per ipheral blood of patients with benign 
and malignant breast disease . Br . J . Cancer 47 :307 -309 . 
Melendro, E. I., C. Saldate, S. J. Rivero , and D. Alarcon -Segovia. 1983 . 
T-cell subpopulations in the peripheral blood of patients with 
connective tissue diseases as determined by flow cytometry using 
monoclonal antibodies : inhibition by suppressor T cells. Clin. 
Irrvnunol . Irrvnunopathol . 27:340 -347. 
Mills , C. D. , and R. J . North. 1983. Expression of passively transferred 
irrvnunity against an established tumor depends on generation of cytolyti c 
T cells in recip ient . J. Exp. Med. 157: 1448-1460. 
Muirhead , K. A. , P. K. Horan, and G. Poste . 1985. Flow cytometry: 
present and future . Bio/ technology 3:337-356. 
Murray, J . L. , P. E. Hurtubise, D. C. Young, S. P. Balcerzak, and A. F. 
Lobuglio. 1980. Correlation of prognostic factors and blood lymphocyte 
subtypes in non -Hodgkin' s lymphoma. Cancer 46:1817- 1824 . 
Nordskog, A. W., and S. Cheng. 1988. Inbreeding effects on fertility and 
hatchability associated with the formation of sublines. Poult. Sci. 
67:859-864. 
Nordskog, A. W., W. A. Rishell, and D. M. Briggs. 1973. Influence of B 
locus blood groups on adult mortality and egg production in the white 
leghorn chicken . Genetics 75:181-189 . 
Parnes, J. R. 1989. Molecular biology and function of C04 and CDS. 
Adv . lrrvnunol. 44:265-3 11 . 
68 
Payne, L. H. 1985. Genetics of cell receptors for avian retrov iruses. 
Pages 1-16 in W. G. Hill , J.M . Manson , and D. Hewitt, eds. Poultry 
genetics and breeding . Briti sh Poultry Science Ltd., Longman Group, 
Harlow, London . 
Perry, L. L., T. N. Wight , W. M. Collins, and W. R. Dunlop . 1978 . 
Differentiation of progressive versus regressive Rous vi rus-induced 
avian sarcomas according to tumor and infiltrating lymphocyte fine 
structure. Poult. Sci. 57 :80-84 . 
Pink, J . R. L., W. Droege , K. Hala , V. C. Miggiano, and A. Ziegler. 1977. 
A three - locus model for the chicken major histocompatibility complex. 
Invnunogenetics 5: 203-216. 
Powell, P. C., K. Hala , and G. Wick. 1987. Aberrant expression of Ia-like 
antigens on tumor cells of regressing but not of progressi ng Rous 
sarcomas. Eur . J . Invnunol. 17:723-726. 
Reinherz , E. L. , P. C. Kung , G. Goldstein, and S. F. Schlossman . 1979a. 
Further characterization of the human inducer T cell subset defined by 
monoclonal antibody . J. Invnunol . 123(6) :2894-2896 . 
Reinherz , E. L., P. C. Kung , G. Goldstein, and S. F. Schlossman . 1979b. 
Separation of functional subsets of human T cells by a monoclonal 
antibody. Proc . Natl . Acad . Sci. USA 76(8) :4061-4065. 
Reinherz, E. L., P. C. Kung, G. Goldstein, and S. F. Schlossman . 1980. 
A monoclonal antibody reactive with the human cytotoxic/ suppressor T 
cell subset previously defined by a heteroanti serum termed TH2 . J. 
Invnunol. 124(3) :1301-1307 . 
Rous, P. 1911 . A sarcoma of the fowl transmi ssi ble by an agent separable 
from the tumor cells . J. Exp . Med . 13:397-411 . 
SASR User ' s Guide: Statistics, Version 5 Edition . 1985 . SAS Institute 
Inc . , Cary, North Carolina. 956 pp . 
Schierman, L. W. , and A. W. Nordskog. 1961. Relationship of blood type to 
histocompatibility in chickens. Sc ience 134:1008-1009. 
Sch ierman, L. W., D. H. Watanabe, and R. A. McBride. 1977 . Genetic 
control of Rous sarcoma regression in chickens: linkage with the major 
histocompatibility complex. Invnunogenetics 5:325-332. 
Schild~ H.-J., B. Kyewski, P. Von Hoegen, and V. Schirrmacher. 1987. 
CD4 helper T cells are required for resistance to a highly metastatic 
tumor . Eur. J . Invnunol. 17:1863-1866. 
69 
Sell, S. 1987. I1m1unology i1m1unopathology and i1m1unity. 4th ed. 
Elsevier Science Publishing Company, New York, New York. 852 pp . 
Steadham, E. M. , S. J. Lamont, I. Kujdych, and A. W. Nordskog. 1987. 
Association of Marek 's disease with Ea -B and invnune response genes in 
subline a~d F~ .populations of the Iowa state Sl leghorn line. 
Poult . Sc1 . 66.571 -575 . 
Svoboda, J. 1988 . Rous sarcoma virus. Pages 267-326 in F. Fenner and A 
Gibbs, eds. Portraits of viruses. A history of virology . Basel, 
Karger . 
Swain, S. L. 1983. T cell subsets and the recognition of MHC class . 
Invnunol. Rev . 74 :129-142. 
Trail, P. A. , and T.-J. Yang. 1985. Canine transmissible venereal 
sarcoma: quantitation of T-lymphocyte subpopulations during progressive 
growth and spontaneous tumor regression. J . Natl. Cancer Inst. 
74(2):461 -467. 
Turner, M. J., M. R. Ford , M. Barrett, J. 0. White, and W. P. Soutter. 
1988. T lymphocytes and cervical intraepithelial neoplasia. Irish 
J. Med. Sci. 157(6):184. 
Wainberg, M. A. , Y. Markson , 0. W. Weiss, and F. Doljanski . 1974 . 
Cellular invnunity against Rous sarcomas of chickens. Preferential 
reactivity against autochthonous target cells as determined by 
lymphocyte adherence and cytotoxicity tests in vitro. Proc . Nat . Acad . 
Sci. USA 71(9):3565-3569 . 
Wang , L.-H. , and H. Hanafusa . 1988. Avian sarcoma viruses. Virus Res. 
9:159-203. 
Whitfill, C. E. , W. J . Akbar, N. R. Gyles, and J. A. Thoma. 1986. 
Transfer of blood lymphocytes and macrophages between histocompatible 
progressor and regres sor chickens infected with Rous sarcoma virus. 
J. Natl. Cancer Inst. 76(6):1185-1191. 
Whitfill , C., J. Allen, N. R. Gyles, Z. Johnson, and J. A. Thoma. 1984 . 
Stimulation of progressor and regressor chicken leukocytes with Con A, 
PHA-P, and Rous sarcoma tumor antigens . Avian Dis . 28(4):944-958. 
Yamamoto , H., M. Takata, and S. Fujimoto . 1987. The role of L3T4-positive 
T lymphocytes in the generation of anti - tumor invnunity in the mouse. 
Jpn. J. Cancer Res . (Gann) 78 :176-184. 
70 
Yamanouchi, K., M. Hayami, S. Mitakura, A. Fukuda , and F. Kobune. 1971. 
Cellular irrmunity induced by Rous sarcoma virus in j apanese qua il . 
II. Effect of thymectomy and bursectomy on oncogenesis of Rous sarcoma 
virus . Jpn . J. Med . Sci. Biol . 24 :1-8. 
71 
ACKNOWLEDGEMENTS 
I would like to thank Dr . Susan Lamont, my major professor, for her 
help and guidance throughout this project . My convnittee members, Dr. 
Suzanne Hendrich and Dr. Don Reynolds also have my gratitude for their 
support and assistance . 
Special thanks are deserved by Ed Steadham, Michael Kaiser, Betty 
Young, and Ann Shuey for all their teaching and assistance. They helped 
make being a graduate student tolerable through the many talks , lunches, 
and snacks. 
Sheri Huerd, Donna Maslak, and Neil Jensen also have my heartfelt 
gratitude . Without them, I would never have made it through the last few 
months of graduate school. Fabian Kausche also deserves special thanks and 
recognition for his long -distance love and support, especially the 
chocolate. 
Finally, I would like to thank my parents and sister for their love 
and support. They helped make this all possible. 
